SCHEMBL3467601

SCHEMBL3467601

O=C(O)N(c1ccccc1)S(=O)(=O)c1ccc(C#CCBr)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
MMP13 P45452 4/20 0.40
ESR1 P03372 5/20 0.39
TAS2R14 Q9NYV8 2/20 0.38
LIMK2 P53671 1/20 0.37
MEN1 O00255 1/20 0.37
MMP2 P08253 2/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
PKM P14618 1/20 0.36
MMP3 P08254 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
CCNA2 P20248 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4014555 0.88 KMT2A (0.44) KMT2AMMP13ESR1TAS2R14LIMK2
SCHEMBL4008265 0.86 LMNA (0.41) KMT2AMEN1HTTCA12CA1
SCHEMBL1859337 0.83 ESR1 (0.39) KMT2AMMP13ESR1MEN1MMP2
SCHEMBL4009251 0.79 HSD11B1 (0.43) MMP13ESR1TAS2R14MMP2KEAP1
SCHEMBL3466973 0.77 CA12 (0.42) KMT2AGAAKEAP1NFE2L2CA12
SCHEMBL1856837 0.76 KMT2A (0.53) KMT2AESR1TAS2R14HTTKEAP1
SCHEMBL4014559 0.74 LMNA (0.41) KMT2AMEN1HTTCA12CA1
SCHEMBL10728056 0.73 CA12 (0.62) KMT2ATAS2R14KEAP1NFE2L2CA12
SCHEMBL1856286 0.72 KMT2A (0.40) KMT2AMMP13ESR1MEN1MMP2
SCHEMBL4007168 0.71 PTGDR2 (0.43) KMT2ATAS2R14MEN1HTTCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed
WO-2009080722-A2 CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER CRYSTAX PHARMACEUTICALS, S.L. (ES) 2009-07-02 WO disclosed